Published in Antimicrob Agents Chemother on August 03, 2009
Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Autophagy (2014) 1.29
Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro. Antimicrob Agents Chemother (2012) 0.82
A novel way to grow hemozoin-like crystals in vitro and its use to screen for hemozoin inhibiting antimalarial compounds. PLoS One (2012) 0.79
Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum. J Med Chem (2016) 0.78
Antiplasmodial activity-aided isolation and identification of quercetin-4'-methyl ether in Chromolaena odorata leaf fraction with high activity against chloroquine-resistant Plasmodium falciparum. Parasitol Res (2014) 0.78
Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med (2008) 17.65
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell (2000) 10.72
Antimalarial drug resistance. J Clin Invest (2004) 8.50
Chloroquine-resistant malaria. J Infect Dis (2001) 4.58
The structure of malaria pigment beta-haematin. Nature (2000) 4.24
Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol (1997) 3.66
On the molecular mechanism of chloroquine's antimalarial action. Proc Natl Acad Sci U S A (1996) 3.29
The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization. Biochem J (2007) 2.27
Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). FEBS Lett (1994) 2.15
Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood (1968) 1.81
Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Malar J (2007) 1.58
Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity. J Med Chem (2000) 1.52
Haemozoin (beta-haematin) biomineralization occurs by self-assembly near the lipid/water interface. FEBS Lett (2006) 1.46
Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum. J Cell Biol (1999) 1.44
PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX. Mol Microbiol (2006) 1.33
The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids. Malar J (2003) 1.28
Mechanism of hemolysis induced by ferriprotoporphyrin IX. J Clin Invest (1981) 1.27
Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Exp Parasitol (2000) 1.24
Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position. J Med Chem (2002) 1.20
Destabilisation and subsequent lysis of human erythrocytes induced by Plasmodium falciparum haem products. Eur J Haematol (2005) 1.11
Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases. Biochem Pharmacol (2007) 1.10
Quinolines and artemisinin: chemistry, biology and history. Curr Top Microbiol Immunol (2005) 1.06
Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth. J Med Chem (1999) 1.05
Ca replacement by cationic amphiphilic drugs from lipid monolayers. Biochem Pharmacol (1980) 1.04
Identification and characterization of heme-interacting proteins in the malaria parasite, Plasmodium falciparum. J Biol Chem (2003) 1.03
COMPLEX FORMATION BETWEEN CHLOROQUINE AND FERRIHAEMIC ACID IN VITRO, AND ITS EFFECT ON THE ANTIMALARIAL ACTION OF CHLOROQUINE. Nature (1964) 1.03
Mechanism of malarial haem detoxification inhibition by chloroquine. Biochem J (2001) 1.02
A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs. Curr Top Med Chem (2006) 1.01
Interactions of quinoline antimalarials with hematin in solution. J Inorg Biochem (2005) 0.92
The effect of ferriprotoporphyrin IX and chloroquine on phospholipid monolayers and the possible implications to antimalarial activity. Biochim Biophys Acta (1983) 0.90
Antimalarial 9-anilinoacridine compounds directed at hematin. Antimicrob Agents Chemother (2003) 0.87
Accelerated denaturation of hemoglobin and the antimalarial action of chloroquine. Antimicrob Agents Chemother (2006) 0.81
Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites. Biochem Pharmacol (2004) 0.79
4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity. Bioorg Med Chem (2005) 0.77
[Preparation and antileukemic activity of quinolizidinylalkyl-derivatives of 4-aminoquinoline and 9-aminoacridine]. Boll Chim Farm (1989) 0.77
Diverse membrane-active agents modify the hemolytic response to ferriprotoporphyrin IX. J Pharmacol Exp Ther (1983) 0.77
Two complementary fluorimetric assays for the determination of aminoquinoline binding and uptake by human erythrocytes in vitro. Anal Biochem (2008) 0.76
Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med (2006) 1.81
4-Alkyl- and 4-phenylcoumarins from Mesua ferrea as promising multidrug resistant antibacterials. Phytochemistry (2004) 1.74
A Plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection. J Antimicrob Chemother (2013) 1.29
Accelerated senescence of human erythrocytes cultured with Plasmodium falciparum. Blood (2003) 1.28
Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position. J Med Chem (2002) 1.20
Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. J Biol Chem (2010) 1.20
Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res (2008) 1.15
Destabilisation and subsequent lysis of human erythrocytes induced by Plasmodium falciparum haem products. Eur J Haematol (2005) 1.11
The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediates. ChemMedChem (2007) 1.11
Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity. Mol Pharm (2005) 1.04
Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains. Bioorg Med Chem Lett (2006) 1.04
Manadoperoxides A-D from the Indonesian sponge Plakortis cfr. simplex. Further insights on the structure-activity relationships of simple 1,2-dioxane antimalarials. J Nat Prod (2010) 1.04
Endoperoxide derivatives from marine organisms: 1,2-dioxanes of the plakortin family as novel antimalarial agents. J Med Chem (2006) 1.03
Prevalence of pfcrt point mutations and level of chloroquine resistance in Plasmodium falciparum isolates from Africa. Infect Genet Evol (2005) 1.03
Antiplasmodial activity of Punica granatum L. fruit rind. J Ethnopharmacol (2009) 1.00
Artemisinin antimalarials do not inhibit hemozoin formation. Antimicrob Agents Chemother (2003) 1.00
Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury. Shock (2008) 1.00
Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenan-induced hindpaw oedema formation in the rat. Eur J Pharmacol (2007) 0.99
Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. Glia (2010) 0.99
Effects of malaria heme products on red blood cell deformability. Am J Trop Med Hyg (2007) 0.98
Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int (2009) 0.98
A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus. J Med Chem (2011) 0.98
Antiplasmodial triterpenoids from the fruits of neem, Azadirachta indica. J Nat Prod (2010) 0.96
Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur J Pharmacol (2008) 0.93
Selective toxicity of dihydroartemisinin on human CD34+ erythroid cell differentiation. Toxicology (2010) 0.93
Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle. Toxicology (2012) 0.93
Differential cytokine pattern in the spleens and livers of BALB/c mice infected with Penicillium marneffei: protective role of gamma interferon. Infect Immun (2003) 0.92
Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action. J Med Chem (2005) 0.91
The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria. Malar J (2011) 0.91
ACS67, a hydrogen sulfide-releasing derivative of latanoprost acid, attenuates retinal ischemia and oxidative stress to RGC-5 cells in culture. Invest Ophthalmol Vis Sci (2009) 0.91
H(2)S-releasing aspirin protects against aspirin-induced gastric injury via reducing oxidative stress. PLoS One (2012) 0.90
Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells. Lung Cancer (2009) 0.89
High antiplasmodial activity of novel plasmepsins I and II inhibitors. J Med Chem (2006) 0.89
Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats. Eur J Pharmacol (2010) 0.89
Modulation of thiol homeostasis induced by H2S-releasing aspirin. Free Radic Biol Med (2010) 0.89
CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives. Malar J (2010) 0.88
Interaction of artemisinins with oxyhemoglobin Hb-FeII, Hb-FeII, carboxyHb-FeII, heme-FeII, and carboxyheme FeII: significance for mode of action and implications for therapy of cerebral malaria. ChemMedChem (2009) 0.88
Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria. Malar J (2010) 0.87
Evidence that haem iron in the malaria parasite is not needed for the antimalarial effects of artemisinin. FEBS Lett (2004) 0.86
Antimalarials based on the dioxane scaffold of plakortin. A concise synthesis and SAR studies. Bioorg Med Chem (2010) 0.86
Natural haemozoin modulates matrix metalloproteinases and induces morphological changes in human microvascular endothelium. Cell Microbiol (2011) 0.85
New prostaglandin derivative for glaucoma treatment. Bioorg Med Chem Lett (2009) 0.85
CRIMALDDI: platform technologies and novel anti-malarial drug targets. Malar J (2013) 0.85
Anti-plasmodial activity of Ailanthus excelsa. Fitoterapia (2007) 0.84
Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity. Neurotox Res (2010) 0.84
Activity against Plasmodium falciparum of cycloperoxide compounds obtained from the sponge Plakortis simplex. J Antimicrob Chemother (2002) 0.84
Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials. J Med Chem (2009) 0.84
Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline. Bioorg Med Chem (2012) 0.84
Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agents. J Med Chem (2012) 0.84
Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studies. J Med Chem (2008) 0.83
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents. J Med Chem (2008) 0.83
Differential effects on angiogenesis of two antimalarial compounds, dihydroartemisinin and artemisone: implications for embryotoxicity. Toxicology (2007) 0.83
Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo. Arterioscler Thromb Vasc Biol (2012) 0.83
Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer. Cancer Res (2012) 0.83
Amodiaquine analogues containing NO-donor substructures: synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria. Eur J Med Chem (2011) 0.82
Damicoside from Axinella damicornis: the influence of a glycosylated galactose 4-OH group on the immunostimulatory activity of alpha-galactoglycosphingolipids. J Med Chem (2005) 0.82
Effects of Plasmodium falciparum-infected erythrocytes on matrix metalloproteinase-9 regulation in human microvascular endothelial cells. Asian Pac J Trop Med (2013) 0.82
Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model. PLoS One (2013) 0.82
Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14). Neurochem Int (2012) 0.81
Phenolic compounds from Achillea millefolium L. and their bioactivity. Acta Biochim Pol (2011) 0.81
ACS84, a novel hydrogen sulfide-releasing compound, protects against amyloid β-induced cell cytotoxicity. Neurochem Int (2011) 0.81
Novel amodiaquine congeners as potent antimalarial agents. Bioorg Med Chem (2008) 0.80
Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs'. Bioorg Med Chem Lett (2004) 0.80
Design and synthesis of potent antimalarial agents based on clotrimazole scaffold: exploring an innovative pharmacophore. J Med Chem (2007) 0.80
Atovaquone-statine "double-drugs" with high antiplasmodial activity. ChemMedChem (2008) 0.80
Does chloroquine really act through oxidative stress? FEBS Lett (2002) 0.80
In vitro studies on the mechanism of action of two compounds with antiplasmodial activity: ellagic acid and 3,4,5-trimethoxyphenyl(6'-O-aalloyl)-beta-D-glucopyranoside. Planta Med (2003) 0.80
Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice. Eur J Pharmacol (2012) 0.80
Endothelin-1 production by a microvascular endothelial cell line treated with Plasmodium falciparum parasitized red blood cells. Clin Sci (Lond) (2002) 0.80
S-diclofenac protects against doxorubicin-induced cardiomyopathy in mice via ameliorating cardiac gap junction remodeling. PLoS One (2011) 0.80